Evidence map›Paper›PMID 25901369›Full record

ArticlePloS one2015

Co-Inactivation of GlnR and CodY Regulators Impacts Pneumococcal Cell Wall Physiology.

Calum Johnston, Hester J Bootsma, Christine Aldridge, Sylvie Manuse, Nicolas Gisch, Dominik Schwudke, Peter W M Hermans, Christophe Grangeasse, Patrice Polard, Waldemar Vollmer and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. The global proteome ofFrontiers in cellular and infection microbiology · 2025
    Article
  4. The oxidative stress response ofFrontiers in microbiology · 2023
    Review
  5. Article
  6. The Cell Wall ofMicrobiology spectrum · 2019
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 4 countries.

Calum JohnstonCentre National de la Recherche Scientifique, LMGM-UMR5100, F-31000 Toulouse, France; Université de Toulouse, UPS, Laboratoire de Microbiologie et Génétique Moléculaires, F-31000 Toulouse, France.
Hester J BootsmaLaboratory of Pediatric Infectious Diseases, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands.
Christine AldridgeCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Richardson Road, Newcastle upon Tyne NE2 4AX, United Kingdom.
Sylvie ManuseBases Moléculaires et Structurales des Systèmes Infectieux, UMR 5086, Université Lyon 1, CNRS, IBCP, F-69007 Lyon, France.
Nicolas GischResearch Center Borstel, Leibniz-Center for Medicine and Biosciences, 23845 Borstel, Germany.
Dominik SchwudkeResearch Center Borstel, Leibniz-Center for Medicine and Biosciences, 23845 Borstel, Germany.
Peter W M HermansLaboratory of Pediatric Infectious Diseases, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands.
Christophe GrangeasseBases Moléculaires et Structurales des Systèmes Infectieux, UMR 5086, Université Lyon 1, CNRS, IBCP, F-69007 Lyon, France.
Patrice PolardCentre National de la Recherche Scientifique, LMGM-UMR5100, F-31000 Toulouse, France; Université de Toulouse, UPS, Laboratoire de Microbiologie et Génétique Moléculaires, F-31000 Toulouse, France.
Waldemar VollmerCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Richardson Road, Newcastle upon Tyne NE2 4AX, United Kingdom.
Jean-Pierre ClaverysCentre National de la Recherche Scientifique, LMGM-UMR5100, F-31000 Toulouse, France; Université de Toulouse, UPS, Laboratoire de Microbiologie et Génétique Moléculaires, F-31000 Toulouse, France.
Centre National de la Recherche Scientifique · FRNewcastle University · GBResearch Center Borstel - Leibniz Lung Center · DERadboud University Medical Center · NLRadboud University Nijmegen · NLStructural and Molecular Basis of Infectious Systems · FRUniversité Claude Bernard Lyon 1 · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

Biotechnology and Biological Sciences Research Council BB/G015902/1
6 · The paper itself

Abstract

CodY, a nutritional regulator highly conserved in low G+C Gram-positive bacteria, is essential in Streptococcus pneumoniae (the pneumococcus). A published codY mutant possessed suppressing mutations inactivating the fatC and amiC genes, respectively belonging to iron (Fat/Fec) and oligopeptide (Ami) ABC permease operons, which are directly repressed by CodY. Here we analyzed two additional published codY mutants to further explore the essentiality of CodY. We show that one, in which the regulator of glutamine/glutamate metabolism glnR had been inactivated by design, had only a suppressor in fecE (a gene in the fat/fec operon), while the other possessed both fecE and amiC mutations. Independent isolation of three different fat/fec suppressors thus establishes that reduction of iron import is crucial for survival without CodY. We refer to these as primary suppressors, while inactivation of ami, which is not essential for survival of codY mutants and acquired after initial fat/fec inactivation, can be regarded as a secondary suppressor. The availability of codY- ami+ cells allowed us to establish that CodY activates competence for genetic transformation indirectly, presumably by repressing ami which is known to antagonize competence. The glnR codY fecE mutant was then found to be only partially viable on solid medium and hypersensitive to peptidoglycan (PG) targeting agents such as the antibiotic cefotaxime and the muramidase lysozyme. While analysis of PG and teichoic acid composition uncovered no alteration in the glnR codY fecE mutant compared to wildtype, electron microscopy revealed altered ultrastructure of the cell wall in the mutant, establishing that co-inactivation of GlnR and CodY regulators impacts pneumococcal cell wall physiology. In light of rising levels of resistance to PG-targeting antibiotics of natural pneumococcal isolates, GlnR and CodY constitute potential alternative therapeutic targets to combat this debilitating pathogen, as co-inactivation of these regulators renders pneumococci sensitive to iron and PG-targeting agents.

Indexed as

AmidohydrolasesBacterial ProteinsCefotaximeCell WallHydrolysisMutationStreptococcus pneumoniaeTransformation, GeneticamidaseAmidohydrolasesBacterial ProteinsCefotaxime

Identifiers

PMID25901369
PMCPMC4406557
OpenAlexW2016173426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.